Panbela Therapeutics Inc. buy Roth Mkm
Start price
27.03.24
/
50%
€90.36
Target price
27.03.25
€23.10
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 27.03.25. The prediction end date can be changed by Roth_Mkm at any time.Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Panbela Therapeutics Inc. | - | - |
iShares Core DAX® | 2.594% | -1.158% |
iShares Nasdaq 100 | 3.553% | -1.727% |
iShares Nikkei 225® | 0.687% | -8.354% |
iShares S&P 500 | 2.209% | -0.942% |
Comments by Roth_Mkm for this prediction
In the thread Panbela Therapeutics Inc. diskutieren
Panbela Therapeutics, Inc. (NASDAQ: PBLA) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $25.00 price target on the stock.
Ratings data for PBLA provided by MarketBeat
Stopped prediction by Roth_Mkm for Panbela Therapeutics Inc.
Panbela Therapeutics Inc.
Start price
Target price
Perf. (%)
€90.36
05.02.24
05.02.24
€23.26
05.02.25
05.02.25
-
15.12.23
15.12.23
Panbela Therapeutics Inc.
Start price
Target price
Perf. (%)
€90.36
18.12.23
18.12.23
€22.90
18.12.24
18.12.24
-
15.12.23
15.12.23